English

Atogepant

Atogepant Featured Image
  • Atogepant

Short Description:

API’s Name CAS No. US DMF EU DMF Patent Expiry Date( U.S)
Atogepant 1374248-81-3  2027   Sep.28, 2035

 

[Indication] 

  • For the preventive treatment of episodic migraine in adults.
  • For the preventive treatment of chronic migraine in adults.


Product Detail

Product Tags

  • Previous:
  • Next:
    • Write your message here and send it to us

    Products categories